References
Regoli D, Cadieux A, D’Orleans-Juste P. Vasoactive peptides and their receptors. Methods Neurosci 1993; 11: 43–86.
Yanagisawa M. The endothelin system, a new target for therapeutic intervention. Circulation 1994; 89: 1320–2.
Anand-Srivastava MB, Trachte GJ. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 1933; 45: 455–97.
Kitamura K, Kangawa K, Kawamoto M, et al. Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma. Biochem Biophys Res Commun 1992; 185: 134–41.
Ichiki Y, Kitamura K, Kangawa K, et al. Organ distribution and characterization of peptides (VIP, CGRP and PHI) that increase cAMP in rat platelets. Biochem Biophys Res Commun 1992; 187: 1587–93.
Said SI, Mutt V. Polypeptide with broad biological activity. Science 1970; 169: 1217–8.
Brain SD, Williams TJ, Tippins JR, et al. Calcitonin gene related peptide is a potent vasodilator. Nature 1985; 313: 534–6.
Kitamura K, Kangawa K, Kawamoto M, et al. AdrenomeduHin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553–60.
Ishiyama Y, Kitamura K, Ichiki Y, et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 1993; 241: 271–3.
Morris HR, Panico M, Etienne T, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 1984; 308: 746–8.
Steenbergh PH, Hoeppener JWM, Zandberg J, et al. Second human calcitonin/CGRP gene. FEBS Lett 1985; 183: 403–7.
Cooper CJS, Willis AC, Clark A, et al. Purification and characterization of a peptide from amyloid rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987; 84: 8628–32.
Kitamura K, Kangawa K, Kojima M, et al. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett 1994; 338: 306–10.
Sakata J, Shimokubo K, Kitamura S, et al. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993; 195: 921–7.
Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989; 74: 1181–95.
o’Halloran DJ, Bloom SR. Calcitonin gene related peptide: a major neuropeptide and the most powerful vasodilator known. BMJ 1991; 302: 739–40.
Nuki C, Kawasaki H, Kitamura K, et al. Vasodilator effect of adrenomedullin and calcitonin gene related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993; 196: 245–51.
DeWitt BJ, Cheng DY, Caminiti GN, et al. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the pulmonary vascular bed of the cat. Eur J Pharmacol 1994; 257: 303–6.
Ishizaka Y, Ishizaka Y, Tanaka M, et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994; 200: 642–6.
Eguchi S, Hirata Y, Kano H, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994; 340: 226–30.
Ebara T, Miura K, Okumura M, et al. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 1994; 263: 69–73.
Takahashi H, Watanabe XT, Nishimura M, et al. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am J Hypertens 1994; 7: 478–82.
Cooper GJS. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev 1994; 15: 163–201.
Kitamura K, Sakata J, Kangawa K, et al. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720–5.
Bradbury AF, Finnie MDA, Smyth DG. Mechanism of C terminal amide formation by pituitary enzymes.; Nature 1982; 298: 686–8.
Bradbury AF, Smyth DG. Modification of the N- and C-termini of bioactive peptides. In: Fricker LD, editor. Peptide biosynthesis and processing. Boca Raton: CRC Press, 1991: 231–50.
Ishimitsu T, Kojima M, Kangawa K, et al. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994; 203: 631–9.
Imagawa M, Chiu R, Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase. C and cAMR Cell 1987; 51: 251–60.
Fink JS, Verhave M, Kasper S, et al. The CGTGA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc Natl Acad Sci USA 1988; 85: 6662–6.
Ichiki Y, Kitamura K, Kangawa K, et al. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338: 6–10.
Sakata J, Shimokubo T, Kitamura K, et al. Distribution and characterization of immunoreactive adrenomedullin in rat tissue and plasma. FEBS Lett 1994; 352: 105–8.
Bean AJ, Zhang X, Hoekfelt T. Peptide secretion: what do we know? FASEB J 1994; 8: 630–8.
Katoh F, Niina H, Kitumura K, et al. Ca2+dependent cosecretion of adrenomedullin and catecholamines mediated by nicotinic receptors in bovine cultured adrenal medullary cells. FEBS Lett 1994; 348: 61–4.
Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160–6.
Sugo S, Minamino N, Shoji H, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-α. Biochem Biophys Res Commun 1994; 203: 719–26.
Washimine H, Kitamura K, Ichiki Y, et al. Proadrenomedullin N-terminal 20 peptide (PAMP) in human tissue, plasma and urine. Biochem Biophys Res Commun 1994; 202: 1081–7.
Kitamura K, Kangawa K, Ishiyama Y, et al. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett 1994; 351: 35–7.
Katoh F, Kitamura K, Niina H, et al. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem 1995; 64: 459–61.
Kitamura K, Ichiki Y, Tanaka M, et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341: 288–90.
Ishimitsu T, Nishikimi T, Saito Y, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158–61.
Tanaka M, Kitamura K, Ichiki Y, et al. Establishment of radioimmunoassay of adrenomedullin and plasma adrenomedullin levels in various diseases. Jpn Cire J 1994; 58: 494.
Nishikimi T, Kitamura K, Saito Y, et al. Clinical studies for the sites of the production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994; 24: 600–4.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kitamura, K., Kangawa, K., Matsuo, H. et al. Adrenomedullin. Drugs 49, 485–495 (1995). https://doi.org/10.2165/00003495-199549040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199549040-00001